Stockreport

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized un [Read more]